Pharmafile Logo
Pharmafocus logo
Advanced Search

Vitamin A nasal spray being trialled for COVID smell loss

September 29, 2021
Research and Development

The University of East Anglia is conducting a 12-week trial to investigate the use of vitamin A nasal spray to …

News

Several rival companies set to launch antiviral pills for COVID-19

September 29, 2021
Research and Development

With Merck and Pfizer preparing to release clinical trial results from its experimental COVID-19 antiviral pills, rivals are lining up …

News

Debunking vaccine myths and growing concerns

September 28, 2021
Manufacturing and Production

Before the COVID-19 pandemic, vaccines were never seen as a quick fix. Preventative vaccines for Ebola, malaria, and the Zika …

Feature
33482625641_c7347cbaba_h

AI and neurology: How machine learning is revolutionising neuroscience

September 28, 2021
Manufacturing and Production

 

Feature
virocell_1_1

ViroCell Biologics announces pivotal partnership with Great Ormond Street

September 28, 2021
Manufacturing and Production

Innovation-driven viral vector manufacturer, ViroCell Biologics, and Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), have announced a …

News
an

Breakthrough drug approved for Crohn’s disease patients in Japan

September 28, 2021
Manufacturing and Production

Takeda has received approval to manufacture and market Alofisel® (darvadstrocel) in Japan. This drug will be used for the treatment …

News

MSD discussing acquisition of Acceleron Pharma for $11 billion

September 28, 2021
Manufacturing and Production

Leading science and technology company, Merck (known as MSD outside the US), is in advanced stages of acquiring Acceleron Pharma …

News

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021
Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …

News
sanofi_hq__boetie_hall_web

Sanofi drops mRNA COVID vaccine candidate amid success of rivals

September 28, 2021
Manufacturing and Production, Medical Communications

French healthcare group Sanofi has announced that it is dropping plans for its mRNA COVID vaccine due to the success …

News

US injectables supplier Hikma acquires Custopharm

September 27, 2021
Sales and Marketing

Multinational pharmaceutical company, Hikma Pharmaceuticals PLC, has announced that it has agreed to acquire Custopharm Inc from Water Street Healthcare …

News

Approval granted for first oral vasculitis treatment in Japan

September 27, 2021
Sales and Marketing

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) has announced that Japan’s Ministry of Health and Labour Welfare (MHLW) has granted …

News
mat-napo-pij34zrzeew-unsplash

AstraZeneca and Sputnik Light combined vaccines reveal antibody growth

September 27, 2021
Sales and Marketing

A clinical study of the combination of AstraZeneca and Sputnik Light vaccines, conducted in Azerbaijan, has revealed strong neutralising antibodies …

News
nigel-tadyanehondo-god2mdnujuu-unsplash

Driver shortages: UK pharmacies left in dark by government

September 27, 2021
Business Services, Medical Communications, Sales and Marketing

Pharmacists in the UK have been left in the dark by the government, as they still don’t know what measures …

News

COVAX to revamp allocation system as smaller countries miss out on doses

September 27, 2021
Medical Communications, Sales and Marketing

COVAX is set to change its vaccine allocation methodology as it does not take into account a country’s vaccinated population, …

News

Theramex pioneers new treatment for post-menopausal women

September 24, 2021
Medical Communications

Theramex has recently launched the first and only body-identical hormone therapy treatment (HRT) for post-menopausal women, in the form of …

News

Eurazeo set to become leading investor in Kurma Partners

September 24, 2021
Medical Communications

Eurazeo has announced its intention to raise its stake in Kurma Partners, a French venture capital firm specialising in biotechnology …

News

AstraZeneca and MSD’s Lynparza shows potential for prostate cancer patients

September 24, 2021
Medical Communications

The PROpel Phase III trial has shown that Lynparza (olaparib) in combination with abiraterone demonstrated a significant improvement in radiographic …

News
az

AstraZeneca and VaxEquity to collaborate on saRNA platform

September 24, 2021
Medical Communications

AstraZeneca and VaxEquity have announced a collaboration to progress VaxEquity’s platform technology through proof of concept to enable the development …

News

CGT Catapult and Quell Therapeutics enter manufacturing collaboration

September 24, 2021
Medical Communications

CGT Catapult and Quell Therapeutics have announced a collaboration to facilitate an expanded manufacturing footprint focusing on the manufacturing capacity …

News

Pfizer COVID-19 vaccine to be given to older and at-risk Americans

September 23, 2021
Business Services

The FDA have approved a booster dose of the Pfizer BioNTech COVID-19 vaccine for those aged 65 and above, as …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025